Andrea Vogel

This study identifies three small molecule inhibitors that reduce macrophage survival and viability, showing therapeutic potential in models of inflammation and cancer.

This study shows that pro- and anti-inflammatory macrophages adjust UCP2 levels based on metabolism and metabolites, with pyruvate and hypoxia playing key roles.

This study identifies cachexia-associated microbial metabolites using computational modeling and metabolomic analyses in a murine cancer model.